The quarterly scientific journal
In the news
BSL3 GMP manufacturing suite – Naobios
Our team at Naobios has qualified a highly-secured BSL3 GMP manufacturing suite in our multipurpose facility to accommodate challenging GMP production projects involving viral vaccines, viral vectors and oncolytic viruses.
Read more
Implementing digital PCR : a quality leap for the quantification of nucleic acids
Our analytical development team has implemented an innovative digital PCR (dPCR) equipment for the development and validation of QC methods used on biopharmaceutical products in GMP and non-GMP setups.
Read more
Our services for Animal Health
Clean Cells has collaborated with the main stakeholders of Animal Health internationally for many years. Our company is widely recognized for its expertise by both the industry and the regulatory authorities. In this context, agencies have taken to Clean Cells to help them improve the regulatory framework relating to medicines for veterinary use. In this respect, Clean Cells will host a webinar at the end of this year delving into regulatory changes instated in Europe last year.
Read more
Characterization of lentiviral vectors and RCL “pool” assay
Clean Cells has partnered with customers on numerous gene therapy testing projects, including dozens of lentiviral vectors and CAR-T products. The company has now developed and validated a novel method to streamline replication competent lentivirus testing under GMPs, known as the RCL “pool” assay.
Read more
Innovations in cell and virus banking
As part of Contract Development and Manufacturing activities, Clean Cells has been involved in dozens of GMP cell and virus banking projects for sponsors around the world. The banks have since been used for the manufacture of all types of biological products ranging from vaccines to gene therapies […]
Read more